BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zane KE, Cloyd JM, Mumtaz KS, Wadhwa V, Makary MS. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J Clin Oncol 2021; 12(9): 725-745 [PMID: 34631439 DOI: 10.5306/wjco.v12.i9.725] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Reichstein D, Brock A, Lietman C, McKean M. Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis. Curr Opin Ophthalmol 2022. [PMID: 36094043 DOI: 10.1097/ICU.0000000000000905] [Reference Citation Analysis]
2 Kaprin AD, Unguryan VM, Petrov LO, Ivanov SA, Nazarova VV, Pobedintseva YA, Filimonov EV, Kruglov EA. Comparative Assessment of Isolated Liver Chemoperfusion Techniques. Kreativnaâ hirurgiâ i onkologiâ 2022;12:5-12. [DOI: 10.24060/2076-3093-2022-12-1-5-12] [Reference Citation Analysis]
3 Kovács A, Bischoff P, Haddad H, Zhou W, Temming S, Schäfer A, Spallek H, Kaupe L, Kovács G, Pinkawa M. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. JPM 2022;12:430. [DOI: 10.3390/jpm12030430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers (Basel) 2021;14:96. [PMID: 35008260 DOI: 10.3390/cancers14010096] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]